Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1–3 Axillary Lymph Node(s) Metastasis

<table>Disease-free survival rates according to the number of lymph nodes removed from the axilla. Removed lymph node(s) (RLN): 1–5 (85 patients) versus 6–9 (206 patients) (<i>P</i> = 0.016); 1–5 versus 10–15 (394 patients) (<i>P </i>= 0.024); 1–5 versus ≥ 16 (239 patients) (<i>P </i>= 0.015); 6–9 versus 10–15 (<i>P </i>= 0.703); 6–9 versus ≥ 16 (<i>P </i>= 0.985); 10–15 versus ≥ 16 (<i>P </i>= 0.593).</table>

International Scholarly Research Notices

fig1

Figure 1

Figure 1: Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1–3 Axillary Lymph Node(s) Metastasis 

Figure 1 | Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1–3 Axillary Lymph Node(s) Metastasis 